ChapterPDF Available

Platelet Rich Fibrin (PRF) Application in Oral Surgery

Authors:

Abstract and Figures

Platelet rich fibrin (PRF) is an autologous biological product which becomes popular day by day and available in a wide variety of fields in medicine. Platelet concentrates which are introduced at the early 90s have evolved over the years. The use such autologous materials have become trendy in recent years to encounter demanding expectations of patients, improve treatment success and maximize patient comfort. Despite its increasing use in dentistry and oral surgery, the most indications and effects are still being discussed. PRF is easily accepted by patients because of its low cost, easy to receive, low donor morbidity, low postoperative complication and infection rate. This biomaterial may be a solution for patients who have strong negative beliefs about the use of allografts and xenografts or who are afraid of complications during the grafting procedure. The objectives of these technologies are to use their synergistic effect to improve the hard and soft tissue regeneration. PRF in oral surgery are used for alveolar bone reconstruction, dental implant surgery, sinus augmentation, socket preservation, osteonecrosis, oroantral fistula closure, struggling with oral ulcers, preventing swelling and edema constitution. This chapter aims to review the clinical applications of platelets in oral surgery and the role of molecular components in tissue healing.
Content may be subject to copyright.
Selection of our books indexed in the Book Citation Index
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us?
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected.
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International authors and editor s
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
126,000
145M
TOP 1%
154
5,100
Chapter
Platelet Rich Fibrin (PRF)
Application in Oral Surgery
AlperSaglanmak, CaglarCinar and AlperGultekin
Abstract
Platelet rich fibrin (PRF) is an autologous biological product which becomes
popular day by day and available in a wide variety of fields in medicine. Platelet
concentrates which are introduced at the early 90s have evolved over the years.
The use such autologous materials have become trendy in recent years to encounter
demanding expectations of patients, improve treatment success and maximize
patient comfort. Despite its increasing use in dentistry and oral surgery, the most
indications and effects are still being discussed. PRF is easily accepted by patients
because of its low cost, easy to receive, low donor morbidity, low postoperative
complication and infection rate. This biomaterial may be a solution for patients
who have strong negative beliefs about the use of allografts and xenografts or who
are afraid of complications during the grafting procedure. The objectives of these
technologies are to use their synergistic effect to improve the hard and soft tissue
regeneration. PRF in oral surgery are used for alveolar bone reconstruction, dental
implant surgery, sinus augmentation, socket preservation, osteonecrosis, oroan-
tral fistula closure, struggling with oral ulcers, preventing swelling and edema
constitution. This chapter aims to review the clinical applications of platelets in
oral surgery and the role of molecular components in tissue healing.
Keywords: platelet rich fibrin, oral surgery, tissue healing, dental implant
. Introduction
In recent years, the question how to increase patient comfort after surgical
interventions became the main topic of oral surgical applications. In addition to
minimally invasive surgical techniques, extra procedures performed during or
after surgery are aimed to reduce postoperative morbidity. As a result of various
researches in recent years, the use of platelet concentrates give rise to improve
patient comfort and enhance healing after the operation.
Surgical techniques to gain bone and soft tissue can be difficult and associated
with higher morbidity. Although they are technique delicate, they just considered
as gold-standard, because of their capacity in healing enhancement [1]. However,
alternative autologous blood derivatives such as platelet rich fibrin (PRF) are
becoming a current issue with its easy use and effectiveness.
PRF is an autologous product acquired from the patient’s own blood and
enters dental field as a second- generation platelet concentrate under the name
PRF [Platelet Rich Fibrin] by Choukroun. Although they are known by different
names according to the centrifugation time (A-PRF, L-PRF, I- PRF, P-PRF) their
Platelets
main rationale is the same. They are increasing the healing capability of the tissue
by releasing growth factors from platelet granules. These factors are essential for
inflammation process and they have positive effect on healing enhancing. Since it is
an autologous product, it does not cause allergic reactions, it can be prepared rapidly
and easily, there is no risk of disease transfer and no risk of donor site morbidity.
The main advantages are controlling inflammation and suppressing infection by
leukocyte and cytokine secretion [2] (Figures  and ).
In order to get in depth information about the supportive effect of PRF
one should know about the healing pattern of injured tissue. There are four
sequential phases of wound healing: Hemostasis, inflammatory, proliferative
and remodeling phase [3]. At hemostasis phase, platelets are essential for blood
clot formation and PRF with rich platelet granules is promotive to accommodate
a strong fibrin network. This blood clot serves as a reservoir which allows cell
migration, adhesion and proliferation. The impact of this fibrin matrix pro-
ceeds throughout the whole healing process. Inflammatory phase starts with
the injury and takes 5–7days approximately. During this phase, platelets are
releasing various growth factors to the injured site that migrate inflammatory
cells (Lymphocytes, macrophages and neutrophils). These factors are PDGF
(Platelet-derived growth factor), VEGF (Vascular endothelial growth factor),
TGF B (Transforming growth factor) and pro-inflammatory cytokines such as
interleukins (IL-1, IL-6, IL-8) and tumor necrosis factor alpha (TNF-α), whose
roles are enhancing angiogenesis and tissue healing. Within the comprising of
new blood vessels with angiogenesis, acidic and hypoxic environment change.
In the proliferative phase, MSCs (Mesenchymal stem cells) releasing from newly
formed blood vessels, BMP’s (Bone morphogenic protein) and TGF-β are playing
an important role in MSCs organism. MSC’s role is inducing osteoblast differenti-
ation. The last but not the least, remodeling phase is characterized as maturation
process. Within this process, vascularity ratio and collagen deposition decreases
and mineral deposition increases with the replacement of woven bone into lamel-
lar one [4–6].
Fibrin forms a matrix for the migration of cells such as fibroblasts and endo-
thelial cells, which are crucial in angiogenesis and new tissue formation. PRF is a
strong fibrin matrix structure, platelets and leukocytes attach on it and activate
degranulated growth factors with the consequence of releasing cytokines. It has
been suggested that PRF, a natural fibrin network, can protect the growth factors
containing in its own structure from proteolysis. Thus growth factors may maintain
their activity for a long time and stimulate tissue regeneration [7].
Figure 1.
Bloodletting of a patient.
Platelet Rich Fibrin (PRF) Application in Oral Surgery
DOI: http://dx.doi.org/10.5772/intechopen.92602
. Types of PRF
The main purpose of using PRF is to release the rich content of alpha granules
of platelets into the environment for therapeutic purposes. In addition to the basic
functions of platelets, the contents of alpha and dense granules are very important
for different processes such as inflammation and angiogenesis [8]. The main differ-
ences between PRF types are their centrifuge speed.
Advanced platelet rich fibrin (A-PRF): It is obtained with longer centrifuga-
tion time and lower rpm. Thus, more neutrophilic granulocytes are present in
the distal region of the clot. Neutrophilic granulocytes contribute to monocyte
differentiation in macrophages (Figure ).
Pure platelet rich fibrin (P-PRF): After the first centrifuge (6min high
speed), transferring the buffy coat and PPP (Platelet poor plasma) to the sec-
ond tube, which contains CaCl2. After the second centrifuge starts and takes
15min long, stable platelet-fibrin takes place. The authenticity of this method
is the presence of separation gel at the first tube.
Leukocyte and platelet rich fibrin (L-PRF): It is very simple and cheap
method. Blood samples are taken into glass tubes without any anticoagulant
and centrifuged immediately at low speed. It is formed three different layers
with acellular plasma, platelet-rich fibrin and erythrocyte layer at the bottom,
respectively. Thrombocyte rich fibrin matrix is very powerful and autologous
biomaterial can be used in different fields in oral surgery.
Injectable platelet rich fibrin (I-PRF): Blood involves high number of leuko-
cytes. However coagulation occurs within few minutes after the centrifugation
has finished. The use of I-PRF [Injectable] is at an early stage. But the results
are very promising in terms of increasing vascularity and soft tissue healing.
Liquid platelet rich fibrin (Liquid-PRF): Liquid-PRF was defined with low-
speed centrifugation (LSC), which allows forming of a liquid-PRF formula of
fibrinogen and thrombin rather than its conversion to fibrin [2].
Figure 2.
PRF membrane preparation.
Platelets
. PRF in post extraction
Tooth extraction has various adverse effects such as pain, bleeding, swelling,
infection etc. Wound healing in the tooth extraction is characterized by bone loss
as a natural process. Furthermore; extraction will result recession around adjacent
teeth and hinders the functional and esthetic prosthetic rehabilitation. PRF have
been shown to play an important role in tissue healing with the releasing growth
factors from alpha granules, regulate cellular events such as cell adhesion, migra-
tion, proliferation, differentiation and extracellular matrix deposition. Major
changes occurred within the first year following extraction, but a major part of
bone resorption takes place only within 3months [9, 10].
The rationale behind the enhancement of PRF in socket healing is very slowly
polymerizing, cell migration and fibrin network capable of proliferation. During
remodeling of the fibrin network many important growth factors from activated
platelets and the release of the matrix glycoproteins. This biochemical structure
gives rise to the tissue regeneration (Figures  and ).
Figure 4.
PRF membrane utilization in guided bone regeneration.
Figure 3.
A-PRF centrifuge device.
Platelet Rich Fibrin (PRF) Application in Oral Surgery
DOI: http://dx.doi.org/10.5772/intechopen.92602
On the other hand the role of PRF in soft tissue healing has been shown at
well-designed meta-analyses. In fact there are no significant differences in alveolar
osteitis, acute inflammation or alveolar infection following tooth extraction. New
bone gain and bone remodeling topic is also contradictory. However it was con-
cluded that PRF is good at decreasing swelling, edema, pain and trismus following
tooth extraction [9–11].
. PRF for maintaining swelling, edema and pain
Modern studies on clinical research showed that PRF aim to increase not only
the success of the treatments but also the patient comfort. In this sense, the use of
autologous products is advantageous such as high acceptability, low risk of disease
transfer, low morbidity and low cost. PRF plays a crucial role in tissue repair. Their
alpha granules include many substances, plenty of growth factors with significant
effects on the inflammatory and proliferative resident cells at the site of injury, like
mesenchymal stem cells, fibroblasts, chondrocytes and osteoblasts. This potential
may be increased by the concentration of the platelets. Certain in-vitro and in-vivo
studies have shown that the use of PRF is significantly advantageous in terms of cell
migration. Most of clinical studies found the use of PRF positive at wound healing.
According to the results of clinical studies, the use of PRF provides an advantage in
soft tissue healing, reducing swelling and trismus and increasing patient comfort.
However evidences on maintaining pain is scarce and pain usually adhere on early
formation of soft tissue healing [12].
. PRF in periodontal treatment
PRF can also be used in regenerative periodontal therapy to enhance hard and
soft tissue wound healing and promote periodontal tissue regeneration. Various
studies have shown the favorable benefit of using PRF as an adjunct to traditional
periodontal surgical techniques. These studies all exhibit improved clinical out-
comes regarding key clinical parameters such as clinical attachment level and
pocket depth with the use of PRF when compared to conventional techniques
applied alone.
The rationale behind this benefit is believed to lie in the differentiation and
proliferation inducing abilities of PRF.The rich source of bioactive cells within
PRF itself stimulate the local environment and regulate the inflammation process,
Figure 5.
PRF membrane application in immediate implantation for filling the buccal gap.
Platelets
thereby enhancing periodontal wound healing and reducing postoperative discom-
fort. In addition to these benefits the PRF sample also inherently supplies growth
factors, releasing them slowly into the wound for 7–14days. Other obvious benefits
include graft stabilization. Furthermore, a possible antimicrobial effect of L-PRF is
also present [13].
Another reason for PRF being favored in periodontal therapy is its multi-
purpose nature. The centrifuged buffy coat can be used alone in defects, combined
with particulate graft materials or as a thin membrane covering in regeneration
techniques. Studies also show that PRF can be used as an alternative to connective
tissue grafts (CTG) in periodontal plastic surgery owing to its cellular contents.
Additionally, the many benefits of PRF use in periodontal therapy also include its
graft stabilization, wound sealing and hemostatic abilities. Evidently, along with its
favorable biologic outcomes and low-cost PRF seems to be almost ideally suited for
various periodontal purposes [13, 14].
The performance of PRF in different periodontal surgery indications was mea-
sured and PRF was found to perform superiorly when compared to conventional
perio-plastic surgeries applied alone. Its use in intra-bony defects and furcation
defects have proved beneficial in reducing pocket depth values, clinical attachment
level gains and bone fill percentages. Improved outcomes in intrabony defects were
obtained when used alone or in conjunction with other biomaterials. In furcation
defects also, traditional flap surgeries tended to perform better when comple-
mented with PRF.Coronally Advanced Flap (CAF) procedures showed improved
results when accompanied with either CTGs or PRF membranes. Compared to each
other however, these two materials seemed to perform similarly. Therefore, it can
only be said that PRF can be considered a suitable alternative to CTGs in periodon-
tal plastic surgery [14, 15].
. PRF in sinus lifting
Implant rehabilitation success is highly related with sufficient bone volume
and density. The posterior maxilla represents a challenging and unique area for
successful dental implant rehabilitation because of its relatively deficient bone
volume and poor bone quality caused by alveolar bone resorption and maxillary
sinus pneumatization. Rehabilitation of posterior maxillary bone volume has been
successes by different procedures, such as Le Fort I osteotomies, onlay grafts and
sinus lifts [16, 17]. Maxillary sinus floor elevation is considered one of the most
successful procedures that can be performed using different grafting materials,
such as autogenous, xenograft, allograft, alloplast and PRF [18, 19].
Autogenous bone with osteogenic, osteoinductive and osteoconductive proper-
ties is still considered to be the gold standard. However, grafting with autogenous
bone is associated with donor site morbidity, extended duration of surgical proce-
dures and the volume of bone graft harvested may be insufficient for the require-
ments. Biomaterials, thus, are promising substitutes for autogenous bone grafts in
maxillary sinus augmentation. Osteoconductive properties of these biomaterials
have been shown in clinical studies with satisfactory clinical outcomes.
On the other hand, these bone graft materials demonstrate lack of osteogenic
and osteoinductive potential with distinct osteogenic capacity and bone formation.
Moreover, some disadvantages, mainly related to a limited availability, prolonged
healing time and impact on host responses can appear when using these bone sub-
stitutes. To overcome these problems, new substances with osteoinductive proper-
ties, such as platelet-rich fibrin (PRF) was recently introduced as replacement or
additional materials in sinus augmentation procedures [20].
Platelet Rich Fibrin (PRF) Application in Oral Surgery
DOI: http://dx.doi.org/10.5772/intechopen.92602
The biologic mediators have osteoinductive properties and they are considered
to accelerate the formation of new bone and to reduce the time interval. The
strengths of PRF comes from promoting the vascularization of bone tissue, reduc-
ing tissue inflammation, improving scaffold mechanics and accelerating new bone
formation [20]. Newly, researchers have paid greater attention to the success of
PRF application in maxillary sinus lifting procedures, but no consensus has been
reached. Some researchers have reported positive effects of PRF application in sinus
augmentation procedures.
Platelet concentrates have been used to accelerate bone generation and improve
healing by releasing growth factors such as transforming growth factor β1 and β2,
platelet-derived growth factor and vascular endothelial growth factor, which are
able to induce angiogenesis and activate cell proliferation.
In the literature there are some different application techniques for PRF in the
sinus augmentation such as PRF as a sole grafting material, PRF with allografts or
PRF with xenografts. All of these techniques have variable clinical, radiographic
and histologic and histomorphometric outcomes.
Mazor etal. [21] and Simonpieri etal. [22] performed sinus lift by using lateral
approach and PRF was used as a sole grafting material and implants were applied
immediately to serve as tent pegs. During the healing period there were no com-
plications. A 100% survival rate was observed in total of 57 sinus lift procedures
and 110 implants during the follow-up period (2years). Radiographic examination
was performed by CT scan or panoramic radiographs about 6months after the
sinus augmentation to examine the bone volume, where the average bone gain was
9.8mm. Histologic and histomorphometric examination accomplished by Mazor
etal. showed that dense collagen matrix, easily identified osteocytes and osteoblasts
in the lacunae and well-organized and vital bone with structured trabeculae with
more than %30 bone matrix.
Choukroun etal. [23] performed sinus augmentation with PRF in combination
with demineralized freeze-dried bone allograft (DFDBA). They found the rate of
vital bone/inert bone%20 both in test and control group but with a reduced healing
time at PRF group.
Zhang etal. [24] applied the PRF/xenograft mixture for the test group and
xenograft as a sole graft material for the control group. They found no statistically
significant difference between the two groups.
In light of this information, although there is not a consensus statement about
the effect of PRF as a grafting material at sinus lifting procedure, still it is a good
alternative material with its osteoinductive properties to enhance hard tissue
healing.
. PRF for preserving bone around implants
Marginal bone loss is an inevitable process which starts immediately follow-
ing implant placement. There have been done plenty of studies since decades
to minimize it. Previous studies about preserving bone around implants, has
focused on soft tissue thickness and it was hypothesized, adequate soft tissue
volume around implants has a positive effect in preserving marginal bone and
PRF is perfect material to augment soft tissue. We know PRF is a good autologous
material to enhance soft tissue healing with its growth factors including VEGF,
PRGF, etc. However researches about PRF usage to augment hard tissue have
contradictory results and there is need to do further detailed randomized con-
trolled clinical studies to know about the effect of PRF preserving marginal bone
[25] (Figures  and ).
Platelets
. PRF in rare clinical scenarios
PRF could also be beneficial with growth factors including in rare clinical
scenarios such as cyst treatment, sinus membrane perforations, oroantral fistulae
closure and osteonecrosis.
Figure 8.
Large sinus membrane perforation.
Figure 6.
Liquid PRF combined with MPM (Mineralized Plasmatic Matrix) and B-TCP graft material for sinus lifting.
Figure 7.
PRF pieces combined with xenograft in guided bone regeneration.
Platelet Rich Fibrin (PRF) Application in Oral Surgery
DOI: http://dx.doi.org/10.5772/intechopen.92602
Oroantral fistula (OAF) constitution is defined a pathological way between
maxillary sinus and oral cavity. It is an unnatural epithelial connection filled with
granulation tissue or polypoid extension of sinus membrane. It can either come into
existence spontaneously following a large maxillary cyst or tumor or as iatrogenic
after tooth extraction or dental implant surgery [26]. An OAF is highly iatrogenic
and depending on the perforation of sinus membrane during surgical interventions
at maxilla. Either this or that way the treatment of perforated sinus membrane is
bringing the tissue free from infection, cleaning the epithelium and repairing the
membrane (Figure ).
There are plenty of methods maintaining with OAF.PRF is one of them which is
recently introduced. The technique is as following; PRF clots obtained by centrifu-
gation should be isolated from PPP (Platelet Poor Plasma) and red blood cells, pre-
pared as thin membranes and applied perforated area layer by layer. The researches
about PRF in OAF closure conclude that, wound healing is faster and there was an
increase in soft tissue thickness during healing. Due to its natural ingredients, there
are no need to use additional materials, thus less donor site morbidity occurs.
Osteonecrosis is another rare clinical scenario which is defined as avascular
bone area surrounding soft tissue on occasion. Various clinical and medical consid-
erations can cause osteonecrosis. It can occur in consequence of bisphosphonates
(including denosumab), medications or iatrogenic dental malpraxis (In proper use
of NaOH2, formaldehyde, devitalizing agents). Either this or that way the healing
of necrotic bone takes 8weeks at least in appropriate circumstances. Osteonecrosis
can conclude either with a demarcation line or heal just as avascular necrosis.
Clinician should choose the treatment modality according to the clinical situation.
The main factor of osteonecrosis is the disturbance of vascular blood supply. The
management of patient with compromised healing in bone is controversial. Despite
the conventional treatment modalities, curettage of necrotic bone, antibiotic usage,
chlorhexidine glukonate; with more complex treatment modalities hyperbaric oxy-
gen therapy, ozone and low dose laser; PRF utilization alone or with these treatment
modalities takes place in recent years (Figure ) [27].
The use of PRF in cyst depends on the same rationale with the enhancement of
soft and hard tissue healing. Researches related to this topic conclude that using
PRF as a graft material is beneficial for shortening healing time and increasing bone
mineral density (Figures –).
Since it has been discovered the synergetic effect of PRF in healing enhancement
of covering oral mucosa, these platelet derivatives became even more important. PRF
Figure 9.
Sinus membrane perforation closure with PRF membrane.
Platelets

involves cytokines, chemokines, and antimicrobial derivatives with growth factors such
as VEGF, which are crucial to support hard and soft tissue in order to heal (Figure ).
. Conclusion and future perspectives
PRF with its strong fibrin matrix, including growth factors and slow release,
has a positive effect on wound healing. The most important factor for success in
oral surgical procedures is early wound healing. This improvement will decrease
the healing time and enhance relatively the healing of underlying bone. PRF’s
effect on decreasing pain, swelling and edema is evidenced based. Thus it is very
promising material in applications mostly associated with soft tissue healing such as
third molar extractions, oroantral fistula closure and alveolar cleft reconstructions.
Figure 11.
Radicular cyst enucleation.
Figure 10.
2 weeks follow up after PRF application of avascular necrosis area in mandible.

Platelet Rich Fibrin (PRF) Application in Oral Surgery
DOI: http://dx.doi.org/10.5772/intechopen.92602
However studies have sparsely mentioned about the positive effect of new bone
formation at sinus lifting, periodontal and peri-implant bone preservation and
alveolar bone augmentation. For future perspectives, with the use of new genera-
tions of PRF with increased growth factor capacity, combined with graft materials,
PRF will appear in more areas in oral surgery applications.
Acknowledgements
Dt. Ali İsik from Istanbul University Dentistry Faculty Department of Oral
Implantology, Istanbul, Turkey has valuable contributions to this book chapter.
Conflict of interest
The authors declare no conflict of interest.
Figure 12.
PRF utilization after cyst enucleation.
Figure 13.
Healing 2 months follow up after PRF augmentation.
Platelets

Author details
AlperSaglanmak*, CaglarCinar and AlperGultekin
Dentistry Faculty, Department of Oral Implantology, Istanbul University, Istanbul,
Turkey
*Address all correspondence to: alper.saglanmak@istanbul.edu.tr
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium,
provided the original work is properly cited.

Platelet Rich Fibrin (PRF) Application in Oral Surgery
DOI: http://dx.doi.org/10.5772/intechopen.92602
References
[1] Sakkas A, Wilde F, Heufelder M,
etal. Autogenous bone grafts in
oral implantology—Is it still a gold
standard”? A consecutive review of 279
patients with 456 clinical procedures.
International Journal of Implant
Dentistry. 2017;(23)
[2] Dohan DM, Choukroun J, Diss A,
etal. Platelet-rich fibrin (PRF): A
second-generation platelet concentrate.
Part I: Technological concepts and
evolution. Oral Surgery, Oral Medicine,
Oral Pathology, Oral Radiology, and
Endodontics. 2006;(3):37-44
[3] Childs DR, Murthy AS.Overview
of wound healing and management.
Surgical Clinics of North America.
2017;(1):189-207
[4] Gurtner GC, Werner S, Barrandon Y,
Longaker MT.Wound repair and
regeneration. Nature. 2008;:314-321
[5] Salvi GE, Bosshardt DD, Lang NP,
etal. Temporal sequence of hard and
soft tissue healing around titanium
dental implants. Periodontology 2000.
2015;(1):135-152
[6] Araújo MG, Silva CO, Misawa M,
etal. Alveolar socket healing: What
can we learn? Periodontology 2000.
2015;(1):122-134
[7] Gomes PS, Daugela P, Poskevicius L,
etal. Molecular and cellular aspects
of socket healing in the absence
and presence of graft materials and
autologous platelet concentrates: A
focused review. Journal of Oral &
Maxillofacial Research. 2019;(3)
[8] Michelson AD.Chapter 6: The
platelet proteome. In: Platelets.
Amsterdam: Elsevier Inc.; 2019
[9] Del Fabbro M, Bucchi C, Lolato A,
etal. Autologous platelet concentrates
to improve post extraction outcomes.
Journal of Oral and Maxillofacial
Surgery. 2017;:1601-1615
[10] Moraschini V, Barboza ESP.Effect
of autologous platelet concentrates
for alveolar socket preservation: A
systematic review. International Journal
of Oral and Maxillofacial Surgery.
2015;:632-641
[11] Nanditha S,
Balamanikandasrinivasan C,
Senthilkumar M, etal. Appraising the
diverse facets of platelet rich fibrin in
surgery through a systematic review.
International Journal of Surgery.
2017;:186-194
[12] Shah N, Cains M.Autologous
platelet concentrates to improve post
extraction outcomes. Evidence-Based
Dentistry. 2018;:118-119
[13] Castro AB, Meschi N,
Temmerman A, etal. Regenerative
potential of leucocyte- and platelet-
rich fibrin. Part A: Intra-bony defects,
furcation defects and periodontal
plastic surgery. A systematic review
and meta-analysis. Journal of Clinical
Periodontology. 2017;(1):67-82
[14] Sculean A, Chappuis V, Cosgarea R.
Coverage of mucosal recessions at
dental implants. Periodontology 2000.
2017;(1):134-140
[15] Krishnamurkar D, Mahendra J,
Ari G, etal. A clinical and histological
evaluation of platelet-rich fibrin and
CGF for root coverage procedure using
coronally advanced flap: A split-mouth
design. Indian Journal of Dental
Research. 2019;(6):970-974
[16] Isaksson S.Evaluation of three
bone grafting techniques for severely
resorbed maxillae in conjunction
with immediate endosseous implants.
The International Journal of Oral &
Maxillofacial Implants. 1994;:679-688
Platelets

[17] Chiapasco M,Casentini P,
Zaniboni M.Bone augmentation
procedures in implant dentistry.
The International Journal of Oral &
Maxillofacial Implants. 2009;:237-259
[18] Yilmaz S, Karaca EO, Ipci SD,
etal. Radiographic and histologic
evaluation of platelet-rich plasma and
bovinederived xenograft combination in
bilateral sinus augmentation procedure.
Platelets. 2013;(4):308-315
[19] Kassolis JD, Reynolds MA.
Evaluation of the adjunctive benefits of
platelet-rich plasma in subantral sinus.
The Journal of Craniofacial Surgery.
2005;(2):280-287
[20] Zhao JH, Tsai CH, Chang YC.
Clinical application of platelet-rich
fibrin as the sole grafting material in
maxillary sinus augmentation. Journal
of the Formosan Medical Association.
2015;(8):779-780
[21] Mazor Z, Horowitz RA, Del
Corso M, etal. Sinus floor augmentation
with simultaneous implant placement
using Choukrouns platelet-rich
fibrin as the sole grafting material: A
radiologic and histologic study at 6
months. Journal of Periodontology.
2009;:2056-2064
[22] Simonpieri A, Choukroun J, Del
Corso M, etal. Simultaneous sinus-lift
and implantation using microthreaded
implants and leukocyte- and platelet-
rich fibrin as sole grafting material: A
six-year experience. Implant Dentistry.
2011;:2-12
[23] Choukroun J, Diss A, Simonpieri A,
etal. Platelet-rich fibrin (PRF): A
second-generation platelet concentrate.
Part V: Histologic evaluations of PRF
effects on bone allograft maturation in
sinus lift. Oral Surgery, Oral Medicine,
Oral Pathology, Oral Radiology, and
Endodontics. 2006;:299-303
[24] Zhang Y, Tangl S, Huber CD, etal.
Effects of Choukrouns platelet-rich
fibrin on bone regeneration in
combination with deproteinized
bovine bone mineral in maxillary
sinus augmentation: A histological
and histomorphometric study. Journal
of Cranio-Maxillo-Facial Surgery.
2012;:321-328
[25] Hehn J, Schwenk T, Striegel M, etal.
The effect of PRF (platelet-rich fibrin)
inserted with a split-flap technique
on soft tissue thickening and initial
marginal bone loss around implants:
Results of a randomized, controlled
clinical trial. International Journal of
Implant Dentistry. 2016;(1):13
[26] Borgonovo AE, Berardinelli FV,
Favale M, etal. Surgical options in
oroantral fistula treatment. The Open
Dentistry Journal. 2012;:94-98
[27] Del Fabbro M, Gallesio G,
Mozzati M.Autologous platelet
concentrates for bisphosphonate-related
osteonecrosis of the jaw treatment and
prevention. A systematic review of the
literature. European Journal of Cancer.
2015;(1):62-74
... Recent studies, such as that by Makki et al. (2021) (Makki et al. 2021), corroborate these findings, highlighting the effectiveness of A-PRF in promoting faster and less painful recovery. In addition, research by Saglanmak, Cinar and Gultekin (2020) (Saglanmak et al. 2020) suggests that the application of A-PRF can significantly improve tissue regeneration and healing. These data indicate that while I-PRF offers benefits in the management of edema, A-PRF may be a more comprehensive and effective option for the overall management of postoperative symptoms in dental surgery. ...
Article
Full-text available
Injectable platelet-rich fibrin (I-PRF) is primarily found in liquid form and plays a role in accelerating vascularization and aiding wound healing. To carry out a critical analysis of the therapeutic potential of injectable platelet-rich fibrin (I-PRF) in the postoperative management of these surgeries. The systematic review protocol for this study included start and end dates, research question, databases, PICO structure, search strategy, inclusion/exclusion criteria, types of studies, measures of effect, screening methods, data extraction/analysis and risk of bias assessment tools. Registered with PROSPERO (CRD42024537367), it guaranteed transparency and quality. Searches were carried out on the PubMed, Scopus, Embase, Wiley Online Library and Web of Science databases. Results: The systematic search in the databases identified 532 studies. After removing duplicates with Rayyan© software, 480 documents remained, of which 15 met the inclusion criteria. After evaluation following the review protocol, 5 studies were considered highly relevant and included in the systematic review. The results indicated not only uncomplicated healing and adequate osseointegration, but also a significant improvement in comfort parameters and post-operative recovery. It was observed that the application of I-PRF accelerated the healing process, reduced pain and edema, and improved soft and hard tissue regeneration.
... Bu faktörler, inflamasyon süreci için gereklidir ve iyileşmeyi artırmada olumlu etkileri vardır. 5 Otolog bir ürün olduğu için alerjik reaksiyonlara neden olmaz, hızlı ve kolay hazırlanabilir, hastalık bulaşma riski ve donör saha morbiditesi riski yoktur. Başlıca avantajları, inflamasyonu kontrol etmek ve lökosit ve sitokin salgısı ile enfeksiyonu baskılamaktır. ...
... PRF serves as a supportive template for tissue regeneration by guiding clot formation through sustaining growth factors and stem cells as a naturally forming fibrin scaffold. There are many applications of PRF in cosmetic medicine and surgery [38][39]. Further research is expected to uncover more benefits to be obtained from PRF's regenerative properties, bioavailability, and autologous nature. ...
Article
Full-text available
Diabetes is a leading chronic illness in the modern world and 19-34% develop chronic diabetic foot ulcers (DFUs) in their lifetime, often necessitating amputation. The reduction in tissue growth factors and resulting imbalance between proteolytic enzymes and their inhibitors, along with systemic factors impairing healing appear particularly important in chronic wounds. Growth factors applied topically have thus been suggested to be a non-invasive, safe, and cost-effective adjunct to improve wound healing and prevent complications. Comprehensive database searches of MEDLINE via PubMed, EMBASE, Cochrane, and ClinicalTrials.gov were performed to identify clinical evidence and ongoing trials. The risk of bias analysis included randomized controlled trials (RCTs) was performed using the Cochrane Risk of Bias 2.0 tool. We included randomized controlled trials that compared the use of a topical biologic growth factor-containing regimen to any other regimen. Primary outcomes of interest were time to wound closure, healing rate, and time. Secondary outcomes included the incidence of adverse events such as infection. A total of 41 trials from 1992-2020 were included in this review, with a total recorded 3,112 patients. Platelet-derived growth factors (PDGF) in the form of becaplermin gel are likely to reduce the time of closure, increase the incidence of wound closure, and complete wound healing. Human umbilical cord-related treatments, dehydrated human amnion and chorion allograft (dHACA), and hypothermically stored amniotic membrane (HSAM), consistently increased the rates and incidence of complete ulcer healing while reducing ulcer size and time to complete ulcer healing. Fibroblast growth factor-1 (FGF1) showed only a slight benefit in multiple studies regarding increasing complete ulcer healing rates and incidence while reducing ulcer size and time to complete ulcer healing, with a few studies showing no statistical difference from placebo. Platelet-rich fibrin (PRF) is consistent in reducing the time to complete ulcer healing and increasing wound healing rate but may not reduce ulcer size or increase the incidence of complete ulcer healing. Targeting the wound healing pathway via the extrinsic administration of growth factors is a promising option to augment wound healing in diabetic patients. Growth factors have also shown promise in specific subgroups of patients who are at risk of significantly impaired wound healing such as those with a history of secondary infection and vasculopathy. As diabetes impairs multiple stages of wound healing, combining growth factors in diabetic wound care may prove to be an area of interest. Evidence from this systematic literature review suggests that topical adjuncts probably reduce time to wound closure, reduce healing time, and increase the healing rate in patients with chronic DFUs.
... i-PRF is a platelet concentrate in liquid form that can be polymerized with bone graft xenograft and is known as sticky bone (sticky PRF), an emerging trend that has gained applications in periodontology and implantology. [12][13][14] There is a paucity of data on the possibility of incorporating L-PRF in PAOO toward achieving a better surgical outcome and healing and the graft materials used in PAOO have not been compared. [15][16][17] The aim of this pilot study was to compare the effectiveness of PRF vs demineralized bone xenograft (DMBM) in affecting the rate of space closure and early wound healing in the PAOO procedure. ...
Article
Full-text available
Objectives To compare the rate of extraction space closure between periodontally accelerated osteogenic orthodontics (PAOO) using platelet-rich fibrin (PRF) (Group 1) and PAOO using demineralized bone xenograft (DMBM) (Group 2) and to compare the level of wound healing between the PRF group vs the DMBM group after PAOO. Materials and Methods A two-arm prospective single blind pilot study with a split-mouth design was used in which 14 patients requiring premolar extraction were divided into two groups: PRF and DMBM. En-masse space closure was carried out with using mini implants after the PAOO procedure. The amount of space closure was measured at five time points with 2-week intervals within 2 months. The gingival healing levels were assessed using early wound healing scores on the first postoperative day. Results The rate of extraction space closure was faster in the experimental quadrant at all time points (T1-T4) in the PRF group and at time points (T3, T4) in the DMBM group. Comparison between experimental quadrants showed a significant increase in the rate of space closure in the PRF group T1 to T3 (P < .05). The PRF group showed higher total early healing scores than the DMBM group. Conclusions PRF, when used in the PAOO procedure, produces a faster rate of space closure with better early wound healing than DMBM.
Article
Gömülü alt 20 yaş dişlerinin çekimi ağız, diş ve çene cerrahisinde en sık uygulanan cerrahi işlemlerdendir. Bu cerrahi işlemde genellikle; bir dizi fizyolojik, hücresel yanıtı uyaran bir travma oluşur. Bu durum trismus, ödem ve ağrı gibi postoperatif semptomların ortaya çıkışını sağlar. Bu komplikasyonların azaltılmasına yönelik çeşitli yöntemler uygulanmaktadır. TZF-KBF gibi otolog kan ürünleri bu etkilerin azaltılması amacı ile kullanılan yöntemlerdendir. Çalışmamızda TZF’ye göre daha zengin büyüme faktörleri içeren ve daha yoğun fibrin yapısı olan KBF’nin, postoperatif ağrı, ödem ve yara iyileşmesi üzerindeki etkilerinin, TZF’ye göre farkını incelemek amaçlanmıştır. Çalışmamızda 2021 Aralık– 2022 Aralık tarihleri arası XXX, Anabilim Dalı’nda kayıt altına alınan bilateral gömülü alt yirmi yaş dişi cerrahisi yapılmış, 18 yaş üstü 30 hastanın bilgileri, formları ve röntgenleri kullanılmıştır. Çalışmamızda ağrının değerlendirilmesi, postoperatif 2. ve 7.günlerde VAS ile ödemin değerlendirilmesi postoperatif 2. ve 7. Günlerde; hastaların, tragus-ağız köşesi, tragus-pogonion ve lateral göz köşesi-angulus mandibula arası mesafelerin ölçülmesiyle, yara iyileşmesinin değerlendirilmesi postoperatif 7. günde LTH yara iyileşme indeksiyle yapılmıştır. Sonuçlar istatistiksel olarak değerlendirilmiştir. Çalışmamızda KBF ve TZF uygulamasının yara iyileşmesine, postoperatif ödeme ve postoperatif ağrıya olan etkileri incelendiğinde; istatistiksel olarak KBF’nin, TZF’den yara iyileşmesinde daha iyi sonuçlar verdiği ve ağrıyı daha fazla azalttığı saptanmıştır. Postoperatif ödem üzerinde ise KBF’nin TZF’ den istatistiksel olarak farklı olmadığı saptanmıştır.
Article
Full-text available
The management of gingival recession associated with esthetic concerns and root hypersensitivity is challenging and its sequelae are based on the assessment of etiological factors and the degree of tissue involvement. Procedures using pedicle flaps, free soft-tissue grafts, combination of pedicle flaps with grafts, barrier membranes, and the use of platelet concentrates are all effective for this purpose. The use of the second-generation platelet concentrate, platelet rich fibrin (PRF) has been widely used. Lately, concentrated growth factor (CGF) has evolved as a promising regenerative material, wherein it also acts as a scaffold and accelerates wound healing due to its dense fibrin meshwork. A 21-year-old male patient presented with bilateral multiple gingival recessions due to faulty tooth brushing. Coronally advanced flap with Zuchelli's technique was planned as a treatment modality. Platelet concentrates PRF and CGF were placed bilaterally during the procedure, and the outcome of the treatment was compared. The percentage of root coverage was clinically evaluated, and histological evaluation was also done to assess the density of fibrin meshwork in the platelet concentrates. Nearly 100% of root coverage was achieved with both PRF and CGF membrane 3 months postoperatively. However, CGF showed satisfactory wound healing by the 10th-day postoperatively compared to PRF. As CGF operates on varying centrifugation to separate cells in the venous blood, thereby resulting in fibrin-rich blocks that are much larger, denser, and richer in growth factors as also shown histologically.
Article
Full-text available
Objectives: The present manuscript aims to critically detail the physiologic process of socket healing, in the absence or presence of grafting materials or platelet concentrates, addressing the associated molecular and cellular events that culminate in the restoration of the lost tissue architecture and functionality. Material and Methods: An electronic search in the National Library of Medicine database MEDLINE through its online site PubMed and Web of Science from inception until May 2019 was conducted to identify articles concerning physiologic process of socket healing, in the absence or presence of grafting materials or platelet concentrates. The search was restricted to English language articles without time restriction. Additionally, a hand search was carried out in oral surgery, periodontology and dental implants related journals. Results: In total, 122 literature sources were obtained and reviewed. The detailed biological events, at the molecular and cellular level, that occur in the alveolus after tooth extraction and socket healing process modulated by grafting materials or autologous platelet concentrates were presented as two entities. Conclusions: Tooth extraction initiates a convoluted set of orderly biological events in the alveolus, aiming wound closure and socket healing. The healing process comprises a wide range of events, regulated by the interplay of cytokines, chemokines and growth factors that determine cellular recruitment, proliferation and differentiation in the healing milieu, in a space- and time-dependent choreographic interplay. Additionally, the healing process may further be modulated by the implantation of grafting materials or autologous platelet concentrates within the tooth socket, aiming to enhance the regenerative outcome.
Article
Full-text available
Background This study assessed the clinical outcomes of graft success rate and early implant survival rate after preprosthetic alveolar ridge reconstruction with autologous bone grafts. Methods A consecutive retrospective study was conducted on all patients who were treated at the military outpatient clinic of the Department of Oral and Plastic Maxillofacial Surgery at the military hospital in Ulm (Germany) in the years of 2009 until 2011 with autologous bone transplantation prior to secondary implant insertion. Intraoral donor sites (crista zygomatico-alveolaris, ramus mandible, symphysis mandible, and anterior sinus wall) and extraoral donor site (iliac crest) were used. A total of 279 patients underwent after a healing period of 3–5 months routinely computer tomography scans followed by virtual implant planning. The implants were inserted using guided oral implantation as described by Naziri et al. All records of all the consecutive patients were reviewed according to patient age, history of periodontitis, smoking status, jaw area and dental situation, augmentation method, intra- and postoperative surgical complications, and surgeon’s qualifications. Evaluated was the augmentation surgical outcome regarding bone graft loss and early implant loss postoperatively at the time of prosthodontic restauration as well a follow-up period of 2 years after loading. Results A total of 279 patients underwent 456 autologous augmentation procedures in 546 edentulous areas. One hundred thirteen crista zygomatico-alveolaris grafts, 104 ramus mandible grafts, 11 symphysis grafts, 116 grafts from the anterior superior iliac crest, and 112 sinus lift augmentations with bone scrapes from the anterior facial wall had been performed. There was no drop out or loss of follow-up of any case that had been treated in our clinical center in this 3-year period. Four hundred thirty-six (95.6%) of the bone grafts healed successfully, and 20 grafts (4.4%) in 20 patients had been lost. Fourteen out of 20 patients with total graft failure were secondarily re-augmented, and six patients wished no further harvesting procedure. In the six patients, a partial graft resorption was detected at the time of implantation and additional simultaneous augmentation during implant insertion was necessary. No long-term nerve injury occurred. Five hundred twenty-five out of 546 initially planned implants in 259 patients could be inserted into successfully augmented areas, whereas 21 implants in 20 patients due to graft loss could not be inserted. A final rehabilitation as preplanned with dental implants was possible in 273 of the 279 patients. The early implant failure rate was 0.38% concerning two out of the 525 inserted implants which had to be removed before the prosthodontic restoration. Two implants after iliac crest augmentation were lost within a period of 2 years after loading, concerning a total implant survival rate after 2 years of occlusal loading rate of 99.6% after autologous bone augmentation prior to implant insertion. Conclusions This review demonstrates the predictability of autologous bone material in alveolar ridge reconstructions prior to implant insertion, independent from donor and recipient site including even autologous bone chips for sinus elevation. Due to the low harvesting morbidity of autologous bone grafts, the clinical results of our study indicate that autologous bone grafts still remain the “gold standard” in alveolar ridge augmentation prior to oral implantation.
Article
Full-text available
Facial peri-implant mucosal recessions represent an increasing complication in implant dentistry and may negatively affect the esthetic outcome and patient satisfaction. The aim of the present paper is to provide a review on the potential causes of facial peri-implant mucosal recessions and to provide a rationale for treatment along with possible treatment options. The available data indicate that soft tissue augmentation around dental implants is possible, but at present there is no evidence demonstrating that the augmented soft tissues are able to influence the peri-implant bone levels (e.g. to limit peri-implant bone loss). Therefore, the rationale to cover or correct peri-implant mucosal recessions are (i) to optimize the possibility for performing an adequate level of oral hygiene, and (ii) to improve esthetics. At present, there is very limited evidence supporting any specific treatment modality for covering peri-implant soft tissue recessions. The limited available data indicate that only shallow peri-implant mucosal recessions (e.g. up to 2 mm) may be treated successfully by means of a coronally advanced flap and subepithelial connective tissue graft or with guided bone regeneration, while no data are available supporting the possibility of covering deep and large peri-implant mucosal recessions.
Article
Full-text available
Aim: To analyse the regenerative potential of Leucocyte- and Platelet Rich Fibrin (L-PRF) during periodontal surgery. Materials and methods: An electronic and hand search were conducted in three databases. Only randomised clinical trials were selected and no follow-up limitation was applied. Pocket depth (PD), clinical attachment level (CAL), bone fill, keratinized tissue width (KTW), recession reduction, and root coverage (%) were considered as outcome. When possible, meta-analysis was performed. Results: Twenty-four articles fulfilled the inclusion and exclusion criteria. Three subgroups were created: intrabony defects (IBDs), furcation defects, and periodontal plastic surgery. Meta-analysis was performed in all the subgroups. Significant PD reduction (1.1±0.5mm, p<0.001), CAL gain (1.2±0.6mm, p<0.001), and bone fill (1.7±0.7mm, p<0.001) were found when comparing L-PRF to open flap debridement (OFD) in IBDs. For furcation defects, significant PD reduction (1.9±1.5mm, p=0.01), CAL gain (1.3±0.4mm, p<0.001), and bone fill (1.5±0.3mm, p<0.001) were reported when comparing L-PRF to OFD. When L-PRF was compared to a connective tissue graft, similar outcomes were recorded for PD reduction (0.2±0.3mm, p>0.05), CAL gain (0.2±0.5mm, p>0.05), KTW (0.3±0.4mm, p>0.05), and recession reduction (0.2±0.3mm, p>0.05). Conclusions: L-PRF enhances periodontal wound healing. This article is protected by copyright. All rights reserved.
Article
Full-text available
Background Previous studies have shown that adequate thickness or initial augmentation of soft tissue has a positive effect on the stability of peri-implant bone. This randomized, controlled trial aimed to evaluate the influence of augmenting soft tissue with platelet-rich fibrin (PRF) on crestal bone and soft tissue around implants. Methods After randomization, 31 fully threaded titanium implants were inserted in 31 patients (16 men and 15 women) in the lower mandible using a split-flap technique. In the test group (10 patients), mucosa was treated with a PRF membrane. In the control group (21 patients), implantation was realized without soft tissue augmentation. Tissue thickness was measured at point of implant insertion (baseline) and at time of reentry after 3 months. Standardized digital radiographs were obtained for evaluation at time of implant placement, reentry after 3 months and at a 6-month follow-up. Data was analyzed by an independent examiner. Results After 6 months, all 31 implants were osteointegrated. Soft tissue augmentation with PRF led to a significant tissue loss. In the test group, the crestal tissue thickness dropped from 2.20 mm ± 0.48 SD at baseline to 0.9 mm ± 1.02 SD at reentry, whereas crestal mucosa in the control group showed higher stability (2.64 mm ± 0.48 SD at baseline to 2.62 mm ± 0.61 SD at reentry). For ethical reasons, the test group was terminated after 10 cases, and the remaining cases were finished within the control group. In the test group, radiographic evaluation showed a mean bone loss of 0.77 mm ± 0.42 SD/0.57 mm ± 0.44 SD (defect depth/defect width) on the mesial side and 0.82 mm ± 0.42 SD/0.62 mm ± 0.36 SD (defect depth/defect width) on the distal side. In the control group, a mean bone loss of 0.72 mm ± 0.61 SD/0.51 mm ± 0.48 mm (defect depth/defect width) on the mesial and 0.82 mm ± 0.77 SD/ 0.57 mm ± 0.58 SD (defect depth /defect width) on the distal side was measured. Conclusions Within the limits of this study and the early determination of the test group, this study concludes that soft tissue augmentation with PRF performed with a split-flap technique cannot be recommended for thickening thin mucosa. Further studies focusing on different techniques and longer follow-ups are needed to evaluate whether PRF is suitable for soft tissue thickening.
Article
Electronic search of Medline, Embase, Scopus and the Cochrane Central Register of Controlled Trials (CENTRAL). Manual search of multiple dental journals and review reference lists. Two authors searched studies without any language or follow-up duration restrictions. Randomised and controlled clinical trials with a minimum of five patients per group and a parallel or split-mouth design were included. Outcome variables assessed comparing APC use included: patient satisfaction, self-reported postoperative quality of life, radiographic bone healing, clinical and radiographic marginal bone remodelling, soft tissue healing and complications such as alveolar osteitis. Methodologic quality of research was assessed using the following parameters: random sequence generation method and allocation concealment, calibration and binding of outcome assessment, comparability of control and treatment groups at entry, clear definition of inclusion and exclusion criteria, clear definition of outcomes assessment and success criteria, completeness of the outcome data reported and explanation for dropouts/withdrawal, recall rate, sample size and number of surgeons involved. Meta-analysis was carried out with data from studies reporting the same outcome measurements at comparable observations times following tooth extraction. Dichotomous outcomes (ie development of alveolar osteitis) for different treatments were expressed as risk ratios with a 95% confidence interval and continuous outcomes (ie quantifiable bone changes) were expressed as mean differences with a 95% confidence interval. Study design risk of bias was assessed using sensitivity analysis. Thirty three studies met the inclusion criteria. Soft tissue healing at seven days after extraction was better when APCs were used (mean difference of 1.01; 95% CI; 0.77 to 1.24). Three months postoperatively, the second mandibular molar distal probing depth was statistically better in the APC group, mean difference of −1.63; (95% CI; −2.05 to −1.22). There were no statistical differences between the APC and control groups for alveolar osteitis, acute inflammation or alveolar infection. Although the percentage of new bone and indirect measurement of bone metabolism were similar for both groups, bone density was statistically better for the APC group, mean difference of 5.06; (95% CI; 1.45 to 8.66). Qualitative analysis found decreased swelling in four of five studies and decreased trismus in two of three studies. The variations between different types of APCs were not evaluated as part of this review. APCs including platelet-rich plasma (PRP), platelet-rich fibrin (PRF) and plasma rich in growth factors (PRGF) can be used following tooth extraction to improve soft tissue healing, probing depth and bone density, as well as to reduce swelling and trismus. However, their use in reducing other postoperative complications such as pain, alveolar osteitis, inflammation, infection, or in improving new bone percentage and metabolism cannot be recommended. Study heterogeneity made it impossible to perform meta-analysis for pain reduction; therefore further studies investigating the effect on pain are required.
Article
Context: Comprehensive reviews on clinical applications of Platelet rich fibrin (PRF) in surgery are limited despite its extensive utilization resulting in a dearth of knowledge on its effectiveness. Hence this article focuses on shedding light to the various applications of PRF pertaining to surgery through a systematic review. Objective: The systematic review is aimed at evaluating the value of PRF in different areas of surgery. Data sources: A systematic review of articles sourced from MEDLINE-pubmed (2008-2017(July)) was done. Additional articles were searched through GOOGLE SCHOLAR and SCIENCE DIRECT. Search terms such as Platelet rich fibrin; Platelet rich fibrin, surgery; Platelet concentrate; second generation concentrate; Applications of PRF in surgery were used. Study selection: Systematic reviews, Randomized control trials, Pilot studies and Case reports were included. Non English articles, in-vitro and animal studies were excluded. Data extraction: Independent sourcing of articles by 3 authors using a set of predefined criteria. Data synthesis: Out of the 25 articles covering various surgical procedures that met the inclusion criteria, positive outcomes were noted in most. Although categorization into one specific type of study was not done, the overall success rate with PRF usage was 78%.No differences between test and control groups were observed in 2 studies and 3 studies showed no significant improvements with the usage of PRF. Limitations: The systematic review did not categorize the study designs while evaluating success rates which might be considered as a shortcoming as case reports were also included. Conclusions: The future propositions are vast and point towards innovative applications of this bio-material possibly in transplant and burn cases if a method of obtaining large amounts can be devised. However since we rely on evidence-based results, further long term studies are needed in distinct areas of applications to decisively prove its effectiveness.
Article
Wound healing is a highly complex chain of events, and although it may never be possible to eliminate the risk of experiencing a wound, clinicians’ armamentarium continues to expand with methods to manage it. The phases of wound healing are the inflammatory phase, the proliferative phase, and the maturation phase. The pathway of healing is determined by characteristics of the wound on initial presentation, and it is vital to select the appropriate method to treat the wound based on its ability to avoid hypoxia, infection, excessive edema, and foreign bodies.